| Aurobindo Pharma Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524804 |
NSE Symbol : AUROPHARMA |
P/E(TTM) : 36.30 |
|
ISIN Demat : INE406A01037 |
Div & Yield% : 0.00 |
EPS(TTM) : 36.91 |
|
Book Value(₹) : 369.16 |
Market Cap(₹Cr) : 77,815.80 |
Face Value(₹) : 1.00 |
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 2,726.38 | 2,759.89 | 2,822.14 | 2,721.43 | 2,883.56 | 2,757.88 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 2,726.38 | 2,759.89 | 2,822.14 | 2,721.43 | 2,883.56 | 2,757.88 |
| Other Operating Income | 20.90 | 29.83 | 26.03 | 10.56 | 33.07 | 66.71 |
| Other Income | 130.15 | 159.52 | 83.77 | 113.98 | 54.26 | 122.66 |
| Total Income | 2,877.43 | 2,949.24 | 2,931.94 | 2,845.97 | 2,970.89 | 2,947.25 |
| Total Expenditure | 1,975.18 | 2,065.02 | 2,051.83 | 2,135.48 | 2,203.48 | 2,103.71 |
| PBIDT | 902.25 | 884.22 | 880.11 | 710.49 | 767.41 | 843.54 |
| Interest | 48.43 | 57.45 | 60.00 | 61.09 | 66.19 | 51.63 |
| PBDT | 853.82 | 826.77 | 820.11 | 649.40 | 701.22 | 791.91 |
| Depreciation | 71.92 | 71.49 | 70.02 | 93.88 | 68.28 | 68.16 |
| Tax | 202.97 | 174.22 | 187.68 | 155.25 | 164.03 | 188.43 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -3.14 | -0.31 | 3.28 | -7.90 | -3.14 | -2.21 |
| Reported Profit After Tax | 582.07 | 581.37 | 559.13 | 408.17 | 472.05 | 537.53 |
| Extra-ordinary Items | -12.87 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 594.94 | 581.37 | 559.13 | 408.17 | 472.05 | 537.53 |
| EPS (Unit Curr.) | 10.02 | 10.10 | 9.63 | 7.03 | 8.13 | 9.21 |
| EPS (Adj) (Unit Curr.) | 10.02 | 10.10 | 9.63 | 7.03 | 8.13 | 9.21 |
| Calculated EPS (Unit Curr.) | 10.02 | 10.01 | 9.63 | 7.03 | 8.13 | 9.25 |
| Calculated EPS (Adj) (Unit Curr.) | 10.02 | 10.01 | 9.63 | 7.03 | 8.13 | 9.25 |
| Calculated EPS (Ann.) (Unit Curr.) | 40.09 | 40.04 | 38.51 | 28.11 | 32.51 | 37.02 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 40.09 | 40.04 | 38.51 | 28.11 | 32.51 | 37.02 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 400.00 | 0.00 | 0.00 | 0.00 |
| Equity | 58.08 | 58.08 | 58.08 | 58.08 | 58.08 | 58.08 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 19,598.16 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 33.09 | 32.04 | 31.19 | 26.11 | 26.61 | 30.59 |
| PBDTM(%) | 31.32 | 29.96 | 29.06 | 23.86 | 24.32 | 28.71 |
| PATM(%) | 21.35 | 21.06 | 19.81 | 15.00 | 16.37 | 19.49 |
